More than 530 million people worldwide living with diabetes are at risk for developing diabetic retinal disease (DRD), the leading cause of ...
Boehringer Ingelheim’s weight-loss drug candidate survodutide could also be effective for liver disease metabolic dysfunction-associated steatohepatitis (MASH), if the results of a mid-stage ...
Bayer and Boehringer Ingelheim both had new data on their HER2-targeting small-molecule drugs to present at the World Conference on Lung Cancer (WCLC), hoping to add new oral therapies to the ...
Company has Khandelwal Jain & Co. as its auditors. As on 30-09-2024, the company has a total of 27.42 Crore shares outstanding.Ritesh Prop Share Price Today is Rs. 27.11 as on 11 Nov, 2024, 03:57 PM ...
Ritesh International Ltd., incorporated in the year 1981, is a Small Cap company (having a market cap of Rs 24.97 Crore) operating in Chemicals sector. Ritesh International Ltd. key Products/Revenue ...